Literature DB >> 15712404

Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping.

Shinhiro Takeda1, Akitoshi Ishizaka, Yuji Fujino, Toshio Fukuoka, Osamu Nagano, Yoshitsugu Yamada, Jun Takezawa.   

Abstract

Because of high mortality and morbidity, acute respiratory distress syndrome (ARDS) continues to be one of the clinical challenges for intensivists. The diagnostic criteria for ARDS published by the American-European consensus conference were over simplified and made it possible to conduct large-scale randomized controlled trails (RCTs). Thus, many RCTs have been conducted in attempts to evaluate new treatment modalities, but many have reported negative results, in part because this definition was too broad to be used as diagnostic criteria. Pulmonary ARDS and extrapulmonary ARDS differ in terms of their morbidity and mortality with the presence of organ failure being an important risk factor for mortality in ARDS patients. The Classification of ARDS into several subgroups, which take the underlying disease into account, might limit the number of patients enrolled in an RCT. Where as this subgroup classification would enable selection of a homogeneous population of ARDS patients and may be a key to conducting more focused RCTs and, therefore, having more reliable results.

Entities:  

Mesh:

Year:  2005        PMID: 15712404     DOI: 10.1016/j.pupt.2004.11.001

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  10 in total

1.  Effect of Ono-EI-600 elastase inhibitor on high-tidal-volume-induced lung injury in rats.

Authors:  Yasuki Fujita; Yuji Fujino; Yoshiko Maeda; Akinori Uchiyama; Takashi Mashimo; Masaji Nishimura
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

2.  A prospective cohort study of ALI/ARDS in the Tohoku district of Japan (second report).

Authors:  Shigeatsu Endo; Shigehiro Shibata; Nobuhiro Sato; Eiji Hashiba; Kimitaka Tajimi; Koji Saito; Kaneyuki Kawamae; Masaki Nakane; Masahiro Murakawa
Journal:  J Anesth       Date:  2010-03-27       Impact factor: 2.078

3.  Ventilatory strategies in septic patients. Results from a nationwide observational trial.

Authors:  D Schädler; G Elke; C Engel; H Bogatsch; I Frerichs; R Kuhlen; R Rossaint; M Quintel; J Scholz; F M Brunkhorst; M Loeffler; K Reinhart; N Weiler
Journal:  Anaesthesist       Date:  2013-01-16       Impact factor: 1.041

4.  External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome.

Authors:  Zhiguo Zhao; Nancy Wickersham; Kirsten N Kangelaris; Addison K May; Gordon R Bernard; Michael A Matthay; Carolyn S Calfee; Tatsuki Koyama; Lorraine B Ware
Journal:  Intensive Care Med       Date:  2017-06-07       Impact factor: 17.440

5.  Local tissue expression of the cell death ligand, fas ligand, plays a central role in the development of extrapulmonary acute lung injury.

Authors:  Rajan K Thakkar; Chun-Shiang Chung; Yaping Chen; Sean F Monaghan; Joanne Lomas-Neira; Daithi S Heffernan; William G Cioffi; Alfred Ayala
Journal:  Shock       Date:  2011-08       Impact factor: 3.454

6.  Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis.

Authors:  L D Bos; L R Schouten; L A van Vught; M A Wiewel; D S Y Ong; O Cremer; A Artigas; I Martin-Loeches; A J Hoogendijk; T van der Poll; J Horn; N Juffermans; C S Calfee; M J Schultz
Journal:  Thorax       Date:  2017-04-27       Impact factor: 9.139

7.  Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury.

Authors:  Mario Perl; Chun-Shiang Chung; Ulrike Perl; Joanne Lomas-Neira; Monique de Paepe; William G Cioffi; Alfred Ayala
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

8.  Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study.

Authors:  Takashi Tagami; Ryoichi Tosa; Mariko Omura; Hidetada Fukushima; Tadashi Kaneko; Tomoyuki Endo; Hiroshi Rinka; Akira Murai; Junko Yamaguchi; Kazuhide Yoshikawa; Nobuyuki Saito; Hideaki Uzu; Yoichi Kase; Makoto Takatori; Hiroo Izumino; Toshiaki Nakamura; Ryutarou Seo; Yasuhide Kitazawa; Manabu Sugita; Hiroyuki Takahashi; Yuichi Kuroki; Takayuki Irahara; Takashi Kanemura; Hiroyuki Yokota; Shigeki Kushimoto
Journal:  J Intensive Care       Date:  2014-12-31

9.  External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome.

Authors:  Lieuwe D Bos; Laura R Schouten; Olaf L Cremer; David S Y Ong; Marcus J Schultz
Journal:  Ann Intensive Care       Date:  2016-09-15       Impact factor: 6.925

10.  Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis.

Authors:  Yoshiaki Tsuboko; Shinhiro Takeda; Seiji Mii; Keiko Nakazato; Keiji Tanaka; Eiji Uchida; Atsuhiro Sakamoto
Journal:  Drug Des Devel Ther       Date:  2012-10-10       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.